Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma
✍ Scribed by NINA TURUNEN; PEETER KARIHTALA; ANNE MÄNTYNIEMI; RAIJA SORMUNEN; ARNE HOLMGREN; VUOKKO L. KINNULA; YLERMI SOINI
- Book ID
- 109343254
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 246 KB
- Volume
- 112
- Category
- Article
- ISSN
- 0365-5555
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Observational studies and randomized trials have demonstrated that hormone replacement therapy (HRT) increases the recipient's risk of developing breast carcinoma. Because it is known that some breast malignancies are hormonally responsive and that others are not, it has
## Abstract Mutations in DNA double‐strand breaks (DSB) repair genes are involved in the pathogenesis of hereditary mammary tumors, it is, however, still unclear whether defects in this pathway may play a role in sporadic breast cancer. In this study, we initially determined mRNA expression of 15 D